1. Home
  2. TRX vs STIM Comparison

TRX vs STIM Comparison

Compare TRX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

N/A

Current Price

$0.93

Market Cap

383.1M

Sector

N/A

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$2.24

Market Cap

120.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRX
STIM
Founded
1990
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.1M
120.4M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
TRX
STIM
Price
$0.93
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$2.36
★ $5.75
AVG Volume (30 Days)
★ 1.9M
667.1K
Earning Date
11-30-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.25
EPS
★ N/A
N/A
Revenue
N/A
★ $52,776,000.00
Revenue This Year
$121.33
$8.63
Revenue Next Year
N/A
$9.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.80
52 Week High
$2.80
$3.44

Technical Indicators

Market Signals
Indicator
TRX
STIM
Relative Strength Index (RSI) 36.60 49.33
Support Level $0.73 $1.19
Resistance Level $1.03 $2.32
Average True Range (ATR) 0.06 0.14
MACD -0.01 0.06
Stochastic Oscillator 8.48 61.72

Price Performance

Historical Comparison
TRX
STIM

About TRX TRX Gold Corporation

TRX Gold Corp is a high-margin and growing gold company advancing the Buckreef Gold Project in Tanzania. Buckreef Gold includes an established open-pit operation and approximately 2,000 tonnes per day process plant with upside potential demonstrated. The group is focused on creating both near-term and long-term shareholder value by increasing gold production to generate positive cash flow to fund the expansion as outlined in the PEA and grow Mineral Resources through exploration. TRX Gold's actions are led by the highest environmental, social, and corporate governance (ESG) standards, evidenced by the relationships and programs that the Company has developed during its nearly two decades of presence in the Geita Region, Tanzania.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: